Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1995 Jun;121(6):327–337. doi: 10.1007/BF01225684

DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome

Heinz Walter Thielmann 1,✉, Odilia Popanda 1, Lutz Edler 2, Axel Böing 3, Ernst Gustav Jung 4
PMCID: PMC12200420  PMID: 7797597

Abstract

The DNA excision repair capacity of 23 primary fibroblast lines from patients with dysplastic nevus syndrome was investigated and DNA repair synthesis (“unscheduled DNA synthesis”) was determined after UV exposure. Seventeen fibroblast lines from normal donors served as controls. The dose/response experiments included up to ten dose levels and two wavelength ranges: UV-C (using a low-pressure mercury lamp emitting predominantly 254-nm light) and UV-B (artificial “sunlamp” radiation centering around 312-nm light). For each dose level, silver grains over fibroblast nuclei were counted by visual inspection. Twelve cell lines were also evaluated for both UV wavelength ranges using a new semi-automatic image analyzing system. This system included components for rapid sequential identification of both fibroblast nuclei and silver grains sited above them. Silver grains over 100 nuclei were determined for each UV dose level. Dose/response curves were established and analyzed by linear regression. As a quantitative term for assessing DNA excision repair capacity of a cell line we calculated the linear increase (G 0) in the number of grains per nucleus, when the UV dose was multiplied by the factor e (i.e. 2.72). The sensitivity of grain detection and resolution ofoverlapping grains was approximately threefold better in visual than in automatic counting, especially when there were more than 70 grains over nuclei. The time recуired for visual conting, however, was tenfold that of automatic counting. The varianceweighted meanG 0 v,w of all fibroblast lines from patients with dysplastic nevus syndrome was found to be 79.1 (±1.8-grains/nucleus, that of fibroblast lines from normal donors was 74.2 (±1.7) grains/nucleus. This difference revealed a slightly better repair capability for cell lines from patients but was at the borderline of detection and, therefore, should not be overinterpreted. From the experimental accuracy achieved by determination of the varianceweighted means of the two groups, we would have been able to detect a difference of 7 and more grains [> 2 x (σnormal + σpatients)]. The variance-weighted meanG o v,w of all fibroblast lines from patients with dysplastic nevus syndrome was found to be 76.4 (±1.4) grains/nucleus, whereas that of fibroblast lines from normal donors was only 66.6 (±1.8) grains/nucleus. This difference was statistically significant and, contrary to expectation, revealed better, not worse post-UV DNA repair capability in cell lines from patients that in those from normal donors. From the experimental accuracy achieved by determination of the variance-weighted means of the two groups, we would have been able to detect a difference of 6.4 or more grains [> 2 x (σnormal + σpatients)]. Variation between cell lines belonging to the same group was expressed by the standard deviation. On average, the standard deviation was in the range 18.2–21.1 grains/nucleus. This variation did not reflect experimental inaccuracy but different responses of individual cell lines to UV irradiation. On the basis of our data, we consider the hypothesis that patients with dysplastic nevus syndrome are prone to melanoma development because of a general defect in post-UV DNA repair to be improbable.

Key Words: Human fibroblasts, Dysplastic nevus syndrome, Malignant melanoma, UV-induced DNA repair, UV-B, UV-C, Unscheduled DNA synthesis, Semi-automatic image analyzing system

Footnotes

This work was supported by the Deutsche Forschungsgemeinschaft, SFB 136

References

  1. Abrahams PJ, Houweling A, Eb AJ van der (1992) High levels of enhanced reactivation of herpes simplex virus in skin fibroblasts from various hereditary cancer-prone syndromes. Cancer Res 52:53–57 [PubMed] [Google Scholar]
  2. Barnhill RL, Hurwitz S, Duray PH, Arons MS (1988) The dysplastic nevus: recognition and management. Plast Reconstr Surg 81: 280–289 [DOI] [PubMed] [Google Scholar]
  3. Barnhill RL, Roush GC, Titus-Ernstoff L, Ernstoff MS, Duray PH, Kirkwood JM (1992) Comparison of nonfamilial and familial melanoma. Dermatology 184:2–7 [DOI] [PubMed] [Google Scholar]
  4. Boorstein RJ, Hilbert TP, Cadet J, Cunningham RP, Teebor GW (1989) UV-induced pyrimidine hydrates in DNA are repaired by bacterial and mammalian DNA glycosylase activities. Biochemistry 28: 6164–6170 [DOI] [PubMed] [Google Scholar]
  5. Boorstein RJ, Hilbert TP, Cunningham RP, Teebor GW (1990) Formation and stability of repairable pyrimidine photohydrates in DNA. Biochemistry 29:10455–10460 [DOI] [PubMed] [Google Scholar]
  6. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ (1978) Origin of familial melanomas from heritable melanocytic lesions. Arch Dermatol 114:732–738 [PubMed] [Google Scholar]
  7. Clark WH Jr, Elder DE, Guerry IV D, Epstein MN, Greene MH, Horn M van (1984) A study of tumor progression: the precursor lesions of superficial speading and nodular melanoma. Hum Pathol 15: 1147–1165 [DOI] [PubMed] [Google Scholar]
  8. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129 [Google Scholar]
  9. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H (1993) Trends in cancer incidence and mortality. IARC Sci Publ 121:379–410 [DOI] [PubMed] [Google Scholar]
  10. Cooke KR, Spears GF, Elder DE, Greene MH (1989) Dysplastic nevi in a population-based survey. Cancer 63:1240–1244 [DOI] [PubMed] [Google Scholar]
  11. Crutcher WA, Sagebiel RW (1984) Prevalence of dysplastic naevi in a community practice. Lancet: I:729 [DOI] [PubMed] [Google Scholar]
  12. Edler L (1994) Biostatistical issues in the design and analysis of multiple or repeated genotoxicity assays. Environ Health Perspect 102 (Suppl 1]: 53–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Elder De (1985) The dysplastic nevus. Pathology 17:291–297 [DOI] [PubMed] [Google Scholar]
  14. Elder DE (1988 Dyplastic nevus syndrome-biological significance. In: Yarbro JW (ed) Semin Oncol 15/6:529–540 [PubMed]
  15. Enninga IC, Groenendijk RTL, Filon AR, Zeeland AA van, Simons JWIM (1986) The wavelength dependence of u.v.-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts. Carcinogenesis 7:1829–1836 [DOI] [PubMed] [Google Scholar]
  16. Evans MK, Bohr VA (1994) Gene-specific DNA repair of UV-induced cyclobutane pyrimidine dimers in some cancer-prone and premature-aging human syndromes. Mutat Res 314:221–231 [DOI] [PubMed] [Google Scholar]
  17. Galloway AM, Liuzzi M, Paterson MC (1994) Metabolic processing of cyclobutyl pyrimidine dimers and (6-4) photoproducts in UV-treated human cells. J Biol Chem 269:974–980 [PubMed] [Google Scholar]
  18. Green A, Siskind V, Bain C, Alexander J (1985) Sunburn and malignant melanoma. Br J Cancer 51:393–397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Fraser MC, Bondi EE, Guerry D, Tuthill R, Hamilton R, LaRossa D (1980) Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet II:1024 [DOI] [PubMed] [Google Scholar]
  20. Greene MH, Fraser MC, Clark WH Jr, Elder DE, Guerry IV D, Kraemer KH (1984) For the record: the history of precursors to malignant melanoma. Arch Dermatol 120:18–20 [PubMed] [Google Scholar]
  21. Greene MH, Clark WH Jr, Tucker MA, Elder DE, Kraemer KH, Guerry IV D, Witmer WK, Thompson J, Matozzo I, Fraser MC (1985) Acquired precursors of cutaneous malignant melanoma. N Engl J Med 312:91–97. [DOI] [PubMed] [Google Scholar]
  22. Greene MH, Tucker MA, Clark WH, Kraemer KH, Elder DE, Fraser MC (1987) Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol 16:792–797 [DOI] [PubMed] [Google Scholar]
  23. Grob JJ, Andrac L, Romano MH, Davin D, Collet-Villette AM, Munoz MH, Bonerandi JJ (1988) Dysplastic nevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol 118: 745–752 [DOI] [PubMed] [Google Scholar]
  24. Halpern AC, Guerry D IV, Elder DE, Clark WH Jr, Synnestvedt M, Norman S, Ayerle R (1991) Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. Arch Dermatol 127:995–999 [PubMed] [Google Scholar]
  25. Hollander M, Wolfe DA (1973) Nonparametric statistical methods. Wiley, New York [Google Scholar]
  26. Holly EA, Kelly JW, Shpall SN, Chiu S-H (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17:459–468 [DOI] [PubMed] [Google Scholar]
  27. Howell JN, Greene MH, Corner RC, Maher VM, McCormick JJ (1984) Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide. Proc Natl Acad Sci USA 81:1179–1183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hürlimann AF, Bohnert E, Schnyder UW, Schnyder UW, Jung EG (1992) Dysplastic nevus syndrome: intrafamilial identification of carriers by cytogenetics. Dermatology 184:223–225 [DOI] [PubMed] [Google Scholar]
  29. Jung EG, Bohnert E, Boonen H (1986) Dysplastic nevus syndrome: ultraviolet hypermutability confirmed in vitro by elevated sister chromatid exchanges. Dermatologica 173:297–300 [DOI] [PubMed] [Google Scholar]
  30. Kopf AW, Lindsay AC, Rogers GS, Friedman RJ, Rigel DS, Levenstein M (1984) Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome. J Am Acad Dermatol 12:656–662 [DOI] [PubMed] [Google Scholar]
  31. Kraemer KH, Greene MH (1985) Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. Dermatol Clin 3: 225–237 [PubMed] [Google Scholar]
  32. Kraemer KH, Greene MH, Tarone R, Clark WH Jr, Guerry IV D (1983) Dysplastic nevi and cutaneous melanoma risk. Lancet II:1076–1077 [DOI] [PubMed] [Google Scholar]
  33. Kraemer KH, Tucker M, Tarone R, Elder De, Clark WH Jr (1986) Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med 315:1615–1616 [DOI] [PubMed] [Google Scholar]
  34. Lynch HT, Fusaro RM, Danes BS, Kimberling WJ, Lynch JF (1983) A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet 8:325–358 [DOI] [PubMed] [Google Scholar]
  35. Lynch HT, Fusaro RM, Lynch JF (1985) A medical and genetic critique of the familial atypical multiple mole melanoma syndrome and the dysplastic nevus syndrome. Am J Dermatopathol 7:107–116 [DOI] [PubMed] [Google Scholar]
  36. Mitchell DL, Nairn RS (1989) The biology of the (6−4) photoproduct. Photochem Photobiol49:805–819 [DOI] [PubMed] [Google Scholar]
  37. Mitchell DL, Haipek CA, Clarkson JM (1985) (6-4) Photoproducts are removed from the DNA of UV-irradiated mammalian cells more efficiently than cyclobutane pyrimidine dimers. Mutat Res 143: 109–112 [DOI] [PubMed] [Google Scholar]
  38. Mitchell DL, Jen J, Cleaver JE (1991) Relative induction of cyclobutane dimers and cytosine photohydrates in DNA irradiated in vitro and in vivo with ultraviolet-C and ultraviolet-B light. Photochem Photobiol 54:741–746 [DOI] [PubMed] [Google Scholar]
  39. Mirzayans R, Sabour M, Paterson MC (1989) Bioreduction of 4-nitroquinoline 1-oxide in dysplastic nevus syndrome fibroblasts. Mutat Res 225:165–169 [DOI] [PubMed] [Google Scholar]
  40. NIH Consensus Conference (1992) Diagnosis and treatment of early melanoma. JAMA 268:1314–1319 [DOI] [PubMed] [Google Scholar]
  41. Peak JG, Peak MJ (1990a) Ultraviolet light induces double-strand breaks in DNA of cultured human P3 cells as measured by neutral filter elution. Photochem Photobiol 52:387–393 [DOI] [PubMed] [Google Scholar]
  42. Peak MJ, Peak JG (1990b) Hydroxyl radical quenching agents afford similar protection against DNA breakage caused by 365-nm UVA or by gamma radiation. Photochem Photobiol 51:649–652 [PubMed] [Google Scholar]
  43. Peak MJ, Peak JG, Carnes BA (1987) Induction of direct and indirect single-strand braks in human cell DNA by far-and near-ultraviolet radiations: action spectrum and mechanisms. Photochem Photobiol 45:381–387 [DOI] [PubMed] [Google Scholar]
  44. Perera MIR, Um K II, Greene MH, Waters HL, Bredlberg A, Kraemer KH (1986) Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res 46:1005–1009 [PubMed] [Google Scholar]
  45. Ramsay RG, Chen P, Imray FP, Kidson C, Lavin MF, Hockey A (1982) Familial melanoma associated with dominant ultraviolet radiation sensitivity. Cancer Res 42:2909–2913 [PubMed] [Google Scholar]
  46. Rhodes AR (1987) Neoplasms: benign neoplasias, hyperplasias, and dysplasias of melanocytes. In: Fitzpatrick TN, Eisen AZ, Wolf K (eds) Dermatology in general medicine, 3rd edn. McGraw-Hill, New York, pp 877–946 [Google Scholar]
  47. Rhodes AR, Harrist TJ, Day CL, Mihm MC Jr, Fitzpatrick TB, Sober AJ (1983) Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 9: 563–574 [DOI] [PubMed] [Google Scholar]
  48. Riedel C, Spohr R (1981) Correcting overlapping counts in dose calibration at high event-densities. Nucl Tracks 5:265–270 [Google Scholar]
  49. Rigel DS, Rivers JK, Kopf AW, Friedman RJ, Vinokur AF, Heilman ER, Levenstein M (1989) Dysplastic nevi. Markers for increased risk for melanoma. Cancer 63:386–389 [DOI] [PubMed] [Google Scholar]
  50. Rosenstein BS, Ducore JM (1983) Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240–546 nm range. Photochem Photobiol38:51–55 [DOI] [PubMed] [Google Scholar]
  51. Rosenstein BS, Mitchell DL (1987) Action spectra for the induction of pyrimidine (6-4)pyrimidone photoproducts and cyclobutane pyrimidine dine dimers in normal human skin fibroblasts. Photochem Photobiol 45:775–780 [DOI] [PubMed] [Google Scholar]
  52. Rosenstein BS, Mitchell DL (1991) The repair of DNA damages induced in normal human skin fibroblasts exposed to simulated sunlight. Radiat Res 126:338–342 [PubMed] [Google Scholar]
  53. Rosenstein BS, Rosenstein RB (1992) Survival, excision repair and inhibition of DNA synthesis in normal human skin fibroblasts exposed to simulated sunlight. J Photochem Photobiol [B] 16: 247–255 [DOI] [PubMed] [Google Scholar]
  54. Roth M, Boyle JM, Müller H (1988) Thymine dimer repair in fibroblasts of patients with dysplastic nevus syndrome (DNS). Experientia 44:169–171 [DOI] [PubMed] [Google Scholar]
  55. Roush GC, Nordlund JJ, Forget B, Gruber SB, Kirkwood JM (1988) Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 17:273–279 [DOI] [PubMed] [Google Scholar]
  56. Sanford KK, Parshad R, Greene MH, Tarone RE, Tucker MA, Jones GM (1987) Hypersensitivity to G2 chromatid radiation damage in familal dysplastic naevus syndrome. Lancet II:1111–1115 [DOI] [PubMed] [Google Scholar]
  57. Seetharam S, Waters HL, Seidman MM, Kraemer KH (1989) Ultraviolet mutagenesis in a plasmid vector replicated in lymphoid cells from a patient with the melanoma-prone disorder dysplastic nevus syndrome. Cancer Res 49:5918–5921 [PubMed] [Google Scholar]
  58. Sigg C, Pelloni F (1988) Dysplastic nevi and germ cell tumors of the testis — a possible further tumor in the spectrum of associated malignancies in dysplastic nevus syndrome. Dermatologica 176: 109–110 [DOI] [PubMed] [Google Scholar]
  59. Sigg C, Pelloni F, Schnyder UW (1989) Gehäufte Mehrfachmelanome bei sporadischem und familiärem dysplastischen Nävuszellnävus-Syndrom. Hautarzt 40:548–552 [PubMed] [Google Scholar]
  60. Smith PJ, Greene MH, Devlin DA, McKeen EA, Paterson MC (1982) Abnormal sensitivity to UV-radiation in cultured skin fibroblasts from patiens with hereditary cutanous malignant melanoma and dysplastic nevus syndrome. Int J Cancer 30:39–45 [DOI] [PubMed] [Google Scholar]
  61. Smith PJ, Greene MH, Adams D, Paterson MC (1983) Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patiens with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma. Carcinogenesis 4: 911–916 [DOI] [PubMed] [Google Scholar]
  62. Snedecor GW and Cochran WG (1967) Statistical methods. Iowa State University Press, Ames, Iowa [Google Scholar]
  63. Thielmann HW, Hagedorn R, Freber W (1985) Evaluation of colonyforming ability experiments using normal and DNA repair-deficient human fibroblast strains and an automatic colony counter. Cytometry 6:130–136 [DOI] [PubMed] [Google Scholar]
  64. Thielmann HW, Edler L, Friemel S (1986) Xeroderma pigmentosum patients from Germany: repair capacity of 45 XP fibroblasts strains of the Mannheim XP collection as measured by colony-forming ability and unscheduled DNA synthesis following treatment with methyl methanesulfonate andN-methyl-N-nitrosourea. J Cancer Res Clin Oncol 112:24–257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Thielmann HW, Edler L, Brucker A, Jung EG (1991a) Fibroblasts derived from patients with dysplastic nevus syndrome are not more sensitive towards 254-nm and 312-nm ultraviolet light than fibroblasts from normal donors. J Cancer Res Clin Oncol 117:65–69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Thielmann HW, Popanda O, Edler L, Jung EG (1991b) Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. Cancer Res 51:3456–3470 [PubMed] [Google Scholar]
  67. Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM (1988) Dysplastic nevi in association with multiple primary melanoma. Cancer Res 48:1015–1018 [PubMed] [Google Scholar]
  68. Tyrell RM, Pidoux M (1989) Singlet oxygen involvement in the inactivation of cultures human fibroblasts by UVA (334 nm, 365 nm), and neav-visible (405 nm) radiations. Photochem Photobiol 49:407–412 [DOI] [PubMed] [Google Scholar]
  69. Wallace SS (1987) The biological consequences of oxidized DNA bases. Br J Cancer 55 [Suppl VIII]: 118–128 [PMC free article] [PubMed] [Google Scholar]
  70. Weiss RB, Gallagher PE (1993) In vivo repair of cytosine hydrates in DNA of cultured human lymphoblasts. Photochem Photobiol 58: 219–225 [DOI] [PubMed] [Google Scholar]
  71. Weiss J, Garbe C, Buttner P, Jung EG (1993) Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects. Recent Results Cancer Res 128:101–118 [DOI] [PubMed] [Google Scholar]
  72. Wood RD (1989) Repair of pyrimidine dimer ultraviolet light photoproducts by human cell extracts. Biochemistry 28:8287–8292 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES